Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
It’s crucial to get the entire picture of the potential benefits and risks of treatment.
An interview with the founder of the National LGBT Cancer Network
The results from an innovative, “virtual” clinical trial were presented at the 2019 ASCO Annual Meeting.
For cancer patients already burdened by the cost of treatment, the situation is maddening.
But much needs to be done to help cancer survivors live longer and healthier lives.
Researchers are continuing to identify potential biomarkers or specific clinical factors to identify the best candidates for treatments.
A Phase II trial reached its primary endpoint of overall response in just over a third of participants.
Anne Baldwin, OT/L, CHT, CLT, is an occupational therapist at the Cleveland Clinic in Ohio.
Anna Stoessinger, who had her stomach and part of her esophagus removed to treat gastric cancer, has beaten the odds in more ways than one.
Could new cancer drugs restore immune responses against HIV?
A new type of immunotherapy shows promising activity against cancers caused by human papillomavirus (HPV).
Steps before starting therapy to keep your reproductive options open.
Robin McGee, PhD, 57, a clinical psychologist and patient advocate, lives in Nova Scotia with her spouse.
The Food and Drug Administration may approve the next site-agnostic treatment in August.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.